Expression of p53 and p21 in bladder carcinoma of Iraqi patients

被引:0
|
作者
Al Chalabi, Rawaa [1 ]
Salih, Shahlaa M. [1 ]
Saad, Sajid [2 ]
Jawad, Hayder [2 ]
机构
[1] Al Nahrain Univ, Coll Biotechnol, Baghdad, Iraq
[2] Al Yrmook Teaching Hosp, Baghdad, Iraq
关键词
Urinary bladder cancer; p53; p21; Immunohistochemistry; UROTHELIAL CARCINOMA; CANCER; MARKERS; MECHANISM;
D O I
10.4081/jbr.2019.7742
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Bladder cancer is an abnormal cellular multiplication without control arising from the urinary bladder urothelium. Cells cycle is a strictly controlled process regulated by protein complexes composed of cyclins and cyclin-dependent kinases and also by several tumor suppressor gene protein products acting at the Go/G1 checkpoint of the cell-cycle. This study was designed to evaluate the frequency of p53 and p21 expression as biomarkers to monitor the disease and compare the results with those of others. Seventy-three tumors with different stages and grades were collected from patients with bladder carcinoma and ten normal bladder biopsies from forensic autopsy. Sections were immunohistochemically stained for p53 and p21. Results revealed that p53 positive immune reactivity was observed in (57.5%) which were exclusively nuclear and no immune reactivity detectable in (42.5%) of tumors, while all normal tissues expressed negative patterns. Positive immune staining of p21 was recorded in (69.5%) and negative p21 immune staining was recorded in 22 (31.1%), as well as ten normal urothelium. Statistically p53 and p21 over-expression was significantly related to stage and grade of tumors (P<0.05).
引用
收藏
页码:34 / 38
页数:5
相关论文
共 50 条
  • [1] Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder
    Shariat, SF
    Kim, J
    Raptidis, G
    Ayala, GE
    Lerner, SP
    [J]. UROLOGY, 2003, 61 (06) : 1140 - 1145
  • [2] Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma
    Chatterjee, SJ
    Datar, R
    Youssefzadeh, D
    George, B
    Goebell, PJ
    Stein, JP
    Young, LL
    Shi, SR
    Gee, C
    Groshen, S
    Skinner, DG
    Cote, RJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) : 1007 - 1013
  • [3] Expression of p53 and p21 in primary glioblastomas
    Gross, MW
    Kraus, A
    Nashwan, K
    Mennel, HD
    Engenhart-Cabillic, R
    Schlegel, J
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 (03) : 164 - 171
  • [4] Significance of P21(WAF-1)(p21) and P53 expression in renal cell carcinoma (RCC).
    Madan, S
    Grignon, D
    Sarkar, F
    Kattar, M
    Yaman, D
    Sakr, W
    Haas, G
    Crissman, J
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 443 - 443
  • [5] p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma
    Qin, LF
    Ng, IOL
    Fan, ST
    Ng, M
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (04) : 424 - 428
  • [6] p53 expression and p21 expression are mutually exclusive in esophageal squamous cell carcinoma
    Hamada, M
    Naomoto, Y
    Shirakawa, Y
    Yamatsuji, T
    Noma, K
    Motoki, T
    Nobuhisa, T
    Okawa, T
    Haisa, M
    Gunduz, M
    Matsuoka, J
    Tanaka, N
    [J]. ONCOLOGY REPORTS, 2004, 11 (01) : 57 - 63
  • [7] Expression of p53 and p21 are independent prognostic factors in patients with serosal invasion by gastric carcinoma
    Ikeguchi, M
    Saito, H
    Katano, K
    Tsujitani, S
    Maeta, M
    Kaibara, N
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (05) : 964 - 970
  • [8] Expression of p53 and p21 and the clinical response for hyperthermochemoradiotherapy in patients with squamous cell carcinoma of the esophagus
    Ishida, Mayumi
    Morita, Masaru
    Saeki, Hiroshi
    Ohga, Takefumi
    Sadanaga, Noriaki
    Watanabe, Masayuki
    Kakeji, Yoshihiro
    Maehara, Yoshihiko
    [J]. ANTICANCER RESEARCH, 2007, 27 (5B) : 3501 - 3506
  • [9] Expression of p53 and p21 Are Independent Prognostic Factors in Patients with Serosal Invasion by Gastric Carcinoma
    Masahide Ikeguchi
    Hiroaki Saito
    Kuniyuki Katano
    Shunichi Tsujitani
    Michio Maeta
    Nobuaki Kaibara
    [J]. Digestive Diseases and Sciences, 1998, 43 : 964 - 970
  • [10] Infrequent expression of p21 is related to altered p53 protein in pancreatic carcinoma
    Hu, YX
    Watanabe, H
    Ohtsubo, K
    Yamaguchi, Y
    Ha, A
    Motoo, Y
    Okai, T
    Sawabu, N
    [J]. CLINICAL CANCER RESEARCH, 1998, 4 (05) : 1147 - 1152